Rare diseases
Investigational molecules
Locations
Back to Italy2 425 clinical trials in Milan, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease
ItalyPhase 1/2 Study of VS-7375 with Drug Combination in Patients with Advanced KRAS G12D‑Mutated Solid Tumors
ItalyPhase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo
ItalyStudy of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients
ItalyA Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration
ItalyPhase 1/2 Study of CR-001 Safety and Dose Finding in Adults with Locally Advanced or Metastatic Solid Tumors
ItalyEvaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A
ItalyA Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors
ItalyStudy of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive
ItalyStudy of MK-1045 alone or with tocilizumab in patients with Non‑Hodgkin Lymphoma to evaluate safety and efficacy
ItalyA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
ItalySafety and Efficacy of Ifinatamab Deruxtecan in Pediatric Patients Under 18 With Relapsed or Refractory Solid Tumors
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, breast cancer prevention, and advanced solid tumors. Studies include evaluation of novel therapeutic approaches and diagnostic methods.
Research emphasizes personalized treatment approaches and preventive interventions for high-risk patients.
Research initiatives targeting neurodegenerative conditions and chronic headache disorders, with studies examining innovative therapeutic approaches.
Focus on developing targeted therapies and understanding disease mechanisms.
Studies investigating treatments for autoimmune conditions and infectious diseases, including preventive approaches and therapeutic interventions.
Emphasis on developing novel preventive strategies and therapeutic solutions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
